A Phase II, Randomised, Multi-Centre Study of Cabazitaxel Versus Abiraterone or Enzalutamide in Poor Prognosis-Metastatic Castration-Resistant Prostate Cancer

Kwan, Edmond (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

NMA Reference Number: HREC/16/MonH/165
Monash Health HREC Ref: 16-266A

Status	Finished
Effective start/end date	4/01/19 → 3/01/24

Clinical Trial Phase

Phase II